NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹216 Cr | ₹311 Cr | ₹340 Cr | ₹351 Cr | ₹51 Cr |
What is the latest Net Current Assets ratio of NECTAR LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹340 Cr |
| Mar2022 | ₹351 Cr |
| Mar2021 | ₹51 Cr |
How is Net Current Assets of NECTAR LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹216 Cr | -30.53 | |
| Mar2024 | ₹311 Cr | -8.59 | |
| Mar2023 | ₹340 Cr | -3.07 | |
| Mar2022 | ₹351 Cr | 582.45 | |
| Mar2021 | ₹51 Cr | - | |
Compare Net Current Assets of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹409.3 Cr | -4.4% | -13.3% | -52.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -4.4% |
-13.3% |
-52.8% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses